The Scientist7y
Avacta Group plc announces positive outcome of proof-of-concept study with Glythera and follow-on drug development partnership
The detailed terms of the license have not been disclosed but Avacta would receive development milestone payments and royalties on sales of an approved drug developed by Glythera. The antibody drug ...
Nature2y
How digital twins of human cells are accelerating drug discovery
DeepLife has deployed and established proof-of-concept for its platform ... to validate the use of digital twins in drug discovery, setting the stage for more widespread adoption of this ...
Nature4y
Revolutionary new medicines from the human gut microbiome
“Each strain is selected for its functionality, via a defined mechanism of action, in a targeted drug ... rapid development of LBPs, 4D moved from discovery to first-in-class proof-of-concept ...
TMCnet14d
Polyrizon Signs Non- Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments
Raanana, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing ... a definitive agreement following ...